18 Paid Clinical Research Studies in Chandler, Arizona

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone marrow (the spongy tissue inside bones) and the spleen becoming larger. The purpose of this study is to

📍 Ironwood Cancer & Res Ctr /ID# 222162 — Chandler, Arizona

💵 In Arm A, participants will receive navitoclax in combination with ruxolitinib.

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clini

📍 Southwest EP — Chandler, Arizona

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid (which is a medication used in

📍 The Institute for Liver Health — Chandler, Arizona

💵 Part 2, all participants will receive elafibranor for a period of up to 5 years or until the total treatment duration (p

Clinical Trial Multi-analyte Blood Test

This is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high r

📍 AZ Liver Health (Chandler) — Chandler, Arizona

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib

📍 AZ Arthritis and Rheumatology /ID# 261848 — Chandler, Arizona

💵 Participants will receive oral tablets of upadacitinib or matching placebo once daily for 52 weeks in Study 1 and Study

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

The trial objectives include evaluating the adequacy of proposed mitigations for the previous pivotal trial of the FemBloc Permanent Contraceptive System and validating the confirm

📍 New Horizons Clinical Trials — Chandler, Arizona

A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants wi

📍 Local Institution - 0003 — Chandler, Arizona

Study of the Use of Orthopulse Photobiomodulation

This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.

📍 Private Practice — Chandler, Arizona

Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants

The objective of this study is to evaluate the pharmacokinetics, safety, and tolerability of one dose of vorasidenib in participants with severe impaired hepatic function compared

📍 Arizona Clinical Trials — Chandler, Arizona

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

The purpose of this study is to examine the safety and tolerability of AZD6234 and AZD9550 in participants with hepatic impairment and participants with normal hepatic function.

📍 Research Site — Chandler, Arizona

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

This study will administer the investigational drug, BDTX-1535 to eligible patients with recurrent high-grade glioma (HGG) and newly-diagnosed glioblastoma (nGBM). BDTX-1535 was de

📍 Chandler Regional Medical Center — Chandler, Arizona

💵 * Participant has adequate bone marrow and organ function as defined by the following laboratory values (as assessed by

Playing Game to Learn About Children's Vaccine Project

This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillo

📍 Community — Chandler, Arizona

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells

📍 Ironwood Cancer and Research Center /ID# 276370 — Chandler, Arizona

💵 Participants will receive IV telisotuzumab vedotin at 1 of 3 dose regimens as part of a 3 year study duration.

A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity

The goal of this clinical trial is to learn if AT673 contributes to additional weight loss and glycemic control when given with semaglutide in participants with overweight/obesity

📍 CenExel Phoenix — Chandler, Arizona

💵 Participants will receive AT673 / placebo injections concurrently with Semaglutide during weekly clinic visits.

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) d

📍 Chandler Clinical Trials — Chandler, Arizona

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibr

📍 Research Site — Chandler, Arizona

💵 Approximately 52 participants will be randomised to receive AZD2389 and approximately 52 participants will receive place

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to unders

📍 Ironwood Cancer & Research Centers — Chandler, Arizona

💵 Participants will receive all the study medications through intravenous (IV) infusions, which means the medicine is give

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and

📍 Ironwood Cancer and Research Centers - Chandler II /ID# 275443 — Chandler, Arizona

💵 This study will be divided into two stages, in the first stage participants will receive increasing doses of telisotuzum